Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.24.3
Condensed Balance Sheets - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 913,420 $ 9,165,179
Marketable securities 2,330,226 4,086,873
Prepaid research and development 112,225 219,817
Deferred offering costs 553,318 147,445
Prepaid expenses and other current assets 280,914 591,734
Total current assets 4,190,103 14,211,048
Equipment and improvements, net 53,667 73,372
Right-of-use asset 133,105 222,227
Total assets 4,376,875 14,506,647
Current liabilities:    
Accounts payable 2,529,220 646,767
Lease obligation, current 145,210 150,095
Accrued expenses and other current liabilities 2,161,374 2,259,955
Insurance premium financing payable 71,662 381,784
Total current liabilities 4,907,466 3,438,601
Lease obligation, net of current portion 0 90,124
Total liabilities 4,907,466 3,528,725
Commitments and contingencies (see Note 13)
Stockholders’ equity:    
Preferred stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding at September 30, 2024 and December 31, 2023 0 0
Common stock, $0.001 par value; 100,000,000 shares authorized; 7,464,070 and 6,186,280 shares issued and outstanding at September 30, 2024 and December 31, 2023 7,464 6,186
Additional paid-in capital 81,748,225 77,871,584
Accumulated other comprehensive income 1,754 877
Accumulated deficit (82,288,034) (66,900,725)
Total stockholders' (deficit) equity (530,591) 10,977,922
Total liabilities and stockholders' equity $ 4,376,875 $ 14,506,647